CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Basal Cell Carcinoma

  • A systematic review on the use of cryotherapy versus other treatments for basal cell carcinoma. 📎

    facebook Share on Facebook
    Abstract Title:

    A systematic review on the use of cryotherapy versus other treatments for basal cell carcinoma.

    Abstract Source:

    Dermatol Online J. 2018 Nov 15 ;24(11). Epub 2018 Nov 15. PMID: 30695972

    Abstract Author(s):

    Catherine N Tchanque-Fossuo, Daniel B Eisen

    Article Affiliation:

    Catherine N Tchanque-Fossuo

    Abstract:

    BACKGROUND:Cryotherapy is a commonly discussed method for treatment of basal cell carcinoma skin cancer. Some uncertainty remains about its efficacy relative to other modalities.

    OBJECTIVE:To determine the efficacy and adverse events profile of cryotherapy for the treatment of basal cell carcinoma compared to other therapeutic options or non-intervention.

    METHODS:We systematically searched PubMed, OVID, Cochrane Library, EMBASE, CINHAL, and CANCERLIT databases for the following terms:"cryotherapy", AND"basal cell carcinoma", OR"cryosurgery"OR"cryoablation"up to April 2018. Two independent reviewers screened the results and extracted the data. Study endpoints included basal cell carcinoma recurrence, cosmetic outcome, and healing time. Study quality was assessed using the Jadad scale.

    RESULTS:Six clinical studies met our inclusion criteria. The efficacy and safety of cryotherapy alone or with curettage in the treatment of primary superficial and nodular basal cell carcinoma was comparable to photodynamic therapy and surgery, respectively. Cryotherapy was inferior to radiation in terms of recurrence rate. Most patients had better cosmetic outcomes with photodynamic therapy and surgery compared to cryotherapy alone, and cryotherapy with curettage.

    CONCLUSION:Current available data suggests equivalent efficacy of cryotherapy alone compared to photodynamic therapy or surgery, but inferior to radiotherapy. More studies are necessary to draw definitive conclusions.

  • Mediterranean dietary pattern and skin cancer risk: A prospective cohort study in French women.

    facebook Share on Facebook
    Abstract Title:

    Mediterranean dietary pattern and skin cancer risk: A prospective cohort study in French women.

    Abstract Source:

    Am J Clin Nutr. 2019 Aug 5. Epub 2019 Aug 5. PMID: 31380561

    Abstract Author(s):

    Yahya Mahamat-Saleh, Iris Cervenka, Marie Al Rahmoun, Isabelle Savoye, Francesca Romana Mancini, Antonia Trichopoulou, Marie-Christine Boutron-Ruault, Marina Kvaskoff

    Article Affiliation:

    Yahya Mahamat-Saleh

    Abstract:

    BACKGROUND:The Mediterranean diet (MD) has been reported to be associated with lower cancer risk. However, while previous studies explored major single components of the MD, only 1 previous study has investigated adherence to the MD in relation to melanoma risk.

    OBJECTIVE:The aim of this study was to explore the relations between adherence to the MD and the risk of skin cancer, including melanomas, basal cell carcinomas (BCCs), and squamous cell carcinomas (SCCs).

    DESIGN:Etude Epidémiologique auprès de femmes de la Mutuelle Générale de l'Education Nationale (E3N) is a prospective cohort of 98,995 French women aged 40-65 y in 1990. Dietary data were collected via a validated food questionnaire in 1993. Adherence to the MD was assessed using a 9-unit dietary score that incorporates intakes of fruit, vegetables, legumes, cereal products, olive oil, fish, dairy products, meat products, and alcohol. We used Cox proportional hazards regression models to compute HRs and 95% CIs adjusted for age and main known skin cancer risk factors.

    RESULTS:From 1993 to 2008, a total of 2003 skin cancer cases were ascertained among 67,332 women, including 404 melanomas, 1367 BCCs, and 232 SCCs. Score of adherence to the MD was associated with lower risk of skin cancer (HR: 0.83; 95% CI: 0.73, 0.93 for high compared with low score, Ptrend = 0.001). MD score was also inversely and linearly associated with risks of melanoma (HR: 0.72; 95% CI: 0.54, 0.96; Ptrend = 0.02) and BCC (HR: 0.77; 95% CI: 0.66, 0.90; Ptrend = 0.0006) but not SCC (HR: 1.08; 95% CI: 0.75, 1.55; Ptrend = 0.68), although with no heterogeneity across skin cancer types (Pheterogeneity = 0.23).

    CONCLUSION:These findings suggest that adherence to the MD is associated with a lower skin cancer risk in women, particularly melanoma and BCC. If confirmed in future research, these findings may have important implications in skin cancer prevention.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.